1998 | | Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
2003 | | Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice. | 김진홍, 유병무, 이기명, 조성원, 주희재, 함기백 |
2006 | | Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial. | 이은현, 함기백 |
2001 | | Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. | 김영배, 함기백 |
2001 | | Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment | 김영배, 조성원, 함기백 |
2001 | | Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. | 김영배, 조성원, 함기백 |
2004 | | Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats. | 함기백 |
2020 | | Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer | 이기명 |
2019 | | Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis | 이광재 |
1997 | | Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. | 김영수, 김진홍, 윤정구, 조성원, 함기백 |
2004 | | Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. | 김영배, 조성원, 함기백 |
2015 | | Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease | 이광재 |